AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Medicare is the largest payer for clinical laboratory services in the United States, spending more than $7 billion annually for laboratory tests. To ensure this money is spent appropriately, the Health and Human Services’ Office of the Inspector General (OIG) continuously monitors payments to check for “suspicious” billing practices.

But what does “suspicious” look like? Where are the critical risks? How do you prevent an audit of your laboratory?

Those are the issues that Gregory Root, Esq., and Charles Root, PhD, co-chief operating officers of the consulting firm CodeMap in Schaumburg, Illinois, will discuss during their 1-hour webinar June 29 from 2-3 p.m. Eastern. Vince Stine, PhD, AACC’s director of government affairs, will moderate the discussion.

“Lab directors and others need to stay informed of the developing risk areas and recent enforcement actions,” said Gregory Root. “Knowing the focus of the OIG and the Department of Justice will help lab managers avoid potential civil and criminal liability.”

However, Root said, labs can take numerous steps to prevent fraud, abuse, or false claims, including implementing and maintaining an effective compliance program and training all employees on the program; training employees about potential risk areas; and performing periodic audits and monitoring.